Importantly, the combined inhibition of KIT- and FGFR-signaling increased growth inhibition in IM-sensitive GIST cells in vitro and in vivo in patient- derived GIST xenografts [43]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.